These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1053840)

  • 1. Delayed hypersensitivity reaction at metastatic tumor sites.
    Gerner RE; Moore GE; Tabron DS
    Rocky Mt Med J; 1975 Jan; 72(1):17-20. PubMed ID: 1053840
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract]   [Full Text] [Related]  

  • 3. Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.
    Barth A; Hoon DS; Foshag LJ; Nizze JA; Famatiga E; Okun E; Morton DL
    Cancer Res; 1994 Jul; 54(13):3342-5. PubMed ID: 8012946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with immunotherapy of malignant tumors].
    Balliuzek FB; Pecherskii VI
    Eksp Khir Anesteziol; 1972; 17(5):3-6. PubMed ID: 4352618
    [No Abstract]   [Full Text] [Related]  

  • 5. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
    Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
    Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [State of the stroma in melanoma in patients with different delayed hypersensitivity reaction to neoplasm antigen].
    Lavnikova GA; Voronina EA; Babakova SV
    Vopr Onkol; 1978; 24(11):24-30. PubMed ID: 741696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
    Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
    Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy of neoplasms. Part I - Assumptions (author's transl)].
    Szmigiel Z; Skotnicki AB
    Przegl Lek; 1975; 32(5):460-5. PubMed ID: 50612
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunology of tumors.
    Burk MW; Mckhann CF
    Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
    [No Abstract]   [Full Text] [Related]  

  • 10. A guinea pig model for tumor immunology. A summary.
    Rapp HJ
    Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy of malignant melanoma with vaccinia virus.
    Roenigk HH; Deodhar S; St Jacques R; Burdick K
    Arch Dermatol; 1974 May; 109(5):668-73. PubMed ID: 4828533
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of immunotherapy for cancer].
    Adler A; Stein JA; Maor M
    Harefuah; 1972 Dec; 83(12):513-7. PubMed ID: 4659015
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic evaluation of the cancer patient during immunotherapy.
    Boehm OR; Boehm BJ; Jewell WR; Humphrey LJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():403-8. PubMed ID: 4633407
    [No Abstract]   [Full Text] [Related]  

  • 14. [A review on mechanism of anti-tumor action of BCG (author's transl)].
    Tokunaga T
    Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients.
    Fossati G; Canevari S; Pierotti MA; Vezzoni P; Porta GD; Vaglini M
    J Natl Cancer Inst; 1979 Jun; 62(6):1381-5. PubMed ID: 286110
    [No Abstract]   [Full Text] [Related]  

  • 16. [Delayed hypersensitivity reaction in malignant melanoma].
    Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
    Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
    [No Abstract]   [Full Text] [Related]  

  • 17. The complexity of unique tumor-specific antigens.
    Wortzel RD; Stauss HJ; Van Waes C; Schreiber H
    Symp Fundam Cancer Res; 1986; 38():161-82. PubMed ID: 3749644
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide.
    Berd D; Maguire HC; Mastrangelo MJ
    Cancer Res; 1986 May; 46(5):2572-7. PubMed ID: 3697996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
    Chang AE; Yoshizawa H; Sakai K; Cameron MJ; Sondak VK; Shu S
    Cancer Res; 1993 Mar; 53(5):1043-50. PubMed ID: 8439951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody-defined antigens on tumor cells.
    Baldwin RW; Embleton MJ; Price MR
    Biomembranes; 1983; 11():285-312. PubMed ID: 6338949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.